Protalix Biotherapeutics Inc. buy marge
Start price
12.04.17
/
50%
€10.35
Target price
26.07.17
€20.00
Performance (%)
-40.29%
End price
26.07.17
€6.18
Summary
This prediction ended on 26.07.17 with a price of €6.18. The BUY prediction by marge for Protalix Biotherapeutics Inc. performed very badly with a performance of -40.29%. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Protalix Biotherapeutics Inc. | 8.943% | 8.943% | 16.068% | 85.083% |
| iShares Core DAX® | 1,43 % | 2,63 % | 12,46 % | 60,35 % |
| iShares Nasdaq 100 | 1,89 % | -0,46 % | 1,25 % | 85,81 % |
| iShares Nikkei 225® | -1,62 % | 11,10 % | 27,38 % | 64,40 % |
| iShares S&P 500 | 1,92 % | 1,16 % | 1,63 % | 59,42 % |
Comments by marge for this prediction
In the thread Protalix Biotherapeutics Inc. diskutieren
marge stimmt der Buy-Einschätzung von datca zu
marge stimmt am 124.2017 der Buy-Einschätzung von datca mit dem Kursziel 2€ zu.Überschrift: Protalix for the Treatment of Cystic Fibrosis and Fabry Disease
(Vom Mitglied beendet)